Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP914152.RAX2VyK7PZ5M0cAZ2YDWa8eXMA0XeDnXzYvsH5Jk1CZ5g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP914152.RAX2VyK7PZ5M0cAZ2YDWa8eXMA0XeDnXzYvsH5Jk1CZ5g130_assertion type Assertion NP914152.RAX2VyK7PZ5M0cAZ2YDWa8eXMA0XeDnXzYvsH5Jk1CZ5g130_head.
- NP914152.RAX2VyK7PZ5M0cAZ2YDWa8eXMA0XeDnXzYvsH5Jk1CZ5g130_assertion description "[To this end, experience with DNMT inhibitors in hematologic malignancies other than MDS is reviewed in an effort to better understand the therapeutic potential of these agents and to define areas of future exploration in these settings.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914152.RAX2VyK7PZ5M0cAZ2YDWa8eXMA0XeDnXzYvsH5Jk1CZ5g130_provenance.
- NP914152.RAX2VyK7PZ5M0cAZ2YDWa8eXMA0XeDnXzYvsH5Jk1CZ5g130_assertion evidence source_evidence_literature NP914152.RAX2VyK7PZ5M0cAZ2YDWa8eXMA0XeDnXzYvsH5Jk1CZ5g130_provenance.
- NP914152.RAX2VyK7PZ5M0cAZ2YDWa8eXMA0XeDnXzYvsH5Jk1CZ5g130_assertion SIO_000772 16341239 NP914152.RAX2VyK7PZ5M0cAZ2YDWa8eXMA0XeDnXzYvsH5Jk1CZ5g130_provenance.
- NP914152.RAX2VyK7PZ5M0cAZ2YDWa8eXMA0XeDnXzYvsH5Jk1CZ5g130_assertion wasDerivedFrom befree-20150227 NP914152.RAX2VyK7PZ5M0cAZ2YDWa8eXMA0XeDnXzYvsH5Jk1CZ5g130_provenance.
- NP914152.RAX2VyK7PZ5M0cAZ2YDWa8eXMA0XeDnXzYvsH5Jk1CZ5g130_assertion wasGeneratedBy ECO_0000203 NP914152.RAX2VyK7PZ5M0cAZ2YDWa8eXMA0XeDnXzYvsH5Jk1CZ5g130_provenance.